A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRD

Staf Longziekten0 个研究点目标入组 25 人开始时间: 2009年1月21日最近更新: 2013年6月10日

适应症

试验速览

暂无简介。

•Subjects included in the study, will be adult patients (age > 18 years) diagnosed with cystic fibrosis-related diabetes for at least one year, stable disease and regularly attending our outpatient clinic.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•Exclusion criteria are: pregnancy, pregnancy wish, transplantation, on waiting list for transplantation, planned surgical procedures, proven cystic fibrosis liver disease or other hepatic disease, proven type 1 diabetes mellitus, renal insufficiency (creatinine clearance < 50ml/min), sepsis, alcohol abuse, severe cardiovascular disease, permanent oxygen use, FEV1 % predicted < 30% and BMI < 19.

发起方

Staf Longziekten